Lower Extremity AmputationNCT06371209
Kinematics of Ewing Amputees
An observational study of Lower Extremity Amputation and Trans-Tibial Amputation, run by Brigham and Women's Hospital at 1 site in United States.
Trial summary
The agonist-antagonist myoneural interface (AMI) construct, known as the Ewing amputation at the trans-tibial level, has been shown to create a bi-directional neural communication platform as a means of controlling and interpreting proprioceptive feedback from a prosthetic joint. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Lower Extremity Amputation, Trans-Tibial Amputation, Traumatic Lower Extremity Amputation
- What is being tested?
- Modified Amputation and Standard Amputation
- Type of treatment
- Surgery or procedure
- How many people
- 32 participants
- Where
- 1 siteUnited States
- Study dates
- 17 May 2022to 1 Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Trans-tibial amputees local to or visiting the Massachusetts area
Who may be able to join
- Unilateral lower extremity amputees
- Greater than 12 months post-amputation procedure
- Possession and use of a working prosthesis as determined by subject's ability to wear it for 8 hours daily
- A stable, well-fitting socket as indicated by no prosthetic modifications within the prior 14 days and no plans to modify it within the following 30 days
- Follow-up visit with their prosthetist within the past 3 months
- The ability to walk independently without an assistive device
- The ability to follow directions and communicate pain or discomfort
Who cannot join
- Patients beyond the stated age restrictions will be excluded
- Patients who have any underlying neurologic, orthopedic, or cardiopulmonary impairment that affects their gait as assessed by the study clinician.
- Patients with any medical or functional limitations preventing them from ambulating safely and independently without an assistive device.
- Patients will be excluded who do not have a prosthesis
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Validating Normal Kinematic Motion in Residual Limb Musculature of Ewing Amputees
The agonist-antagonist myoneural interface (AMI) construct, known as the Ewing amputation at the trans-tibial level, has been shown to create a bi-directional neural communication platform as a means of controlling and interpreting proprioceptive feedback from a prosthetic joint. In AMI constructs, agonist-antagonist muscles are mechanically coupled within the residual limb, and volitional contraction of an agonist passively stretches that muscle's antagonist. The natural neural responses from muscle spindles within both muscles are then interpreted by the central nervous system as sensations of joint position and speed, associated with movement of the prosthesis.
The aim of this research protocol is to evaluate the electromyographic and kinematic patterns of participants who have undergone unilateral lower extremity Ewing Amputation in order to determine how similar their residual limb data is when compared to their intact limb data. A secondary aim of this research may include comparison of the Ewing participant cohort's biomechanical patterns to a similar cohort of participants who have undergone standard amputation.
The investigators hypothesize that the affected limb of patients with the Ewing procedure will demonstrate a pattern of electromyographic activation of their AMI constructs and kinematic data that recapitulates the pattern seen in their intact limb. The investigators secondarily hypothesize that the kinematic assessment of Ewing Amputation patients will demonstrate patterns that are significantly more physiologic than those witnessed in similar assessments of standard amputees.
Read the detailed description
The specific aim of this research protocol is to evaluate the electromyographic and kinematic patterns of participants who have undergone unilateral lower extremity Ewing Amputation in order to determine how similar their residual limb data is when compared to their intact limb data. A secondary aim of this research may include comparison of the Ewing participant cohort's biomechanical patterns to a similar cohort of participants who have undergone standard amputation.
The investigators hypothesize that the affected limb of participants with the Ewing procedure will demonstrate a pattern of electromyographic activation of their AMI constructs and kinematic data that recapitulates the pattern seen in their intact limb. The investigators secondarily hypothesize that the kinematic assessment of Ewing Amputation participants will demonstrate patterns that are significantly more physiologic than those witnessed in similar assessments of standard amputees.
This will be a cross-sectional study with only one visit. A convenience sample of 16 participants who have previously undergone a lower extremity Ewing amputation will be recruited for the proposed study. Participants may subsequently be matched with up to 16 control participants who have previously undergone standard amputation procedures.
Participants will be assessed in a single session in the Motion Analysis Lab (MAL) at Spaulding Rehabilitation Hospital (SRH). Each visit will consist of the procedures described below and is expected to last about two and a half (2.5) hours.
The investigators will collect demographic data for each participant to help with the study population characterization. Such data will include questions about past medical and surgical history, height, weight, and prosthetic and functional history. In addition to self-reported data from the participant, the investigators may review the electronic medical record of any Mass General Brigham (MGB) participant in order to confirm demographic information.
Clinical tests may be conducted by the investigators to assess participant's lower extremities. Clinical tests may include functional examination of each participant's range of motion (ROM) and muscular strength for the lower extremities. Passive hip movements (flexion, abduction, adduction, internal and external rotation), knee flexion and extension, and ankle dorsiflexion and plantar flexion may be assessed with a goniometer if the joint is present for each limb.
Gait evaluations will be performed in the MAL during one session. Participants will be asked to change into shorts and a short-sleeved shirt (such articles of clothing can be provided by the lab if needed). Data will be gathered simultaneously with an electromyographic (EMG) system and a motion capture system. Both systems are part of SRH inventory and are routinely used in clinical care.
The spatio-temporal parameters, kinematic data and electromyographic data obtained from the Motion Capture System are the primary outcomes. As an exploratory analysis, the investigators will seek the possibility of assessing other items such as symmetry measurements and energy recovery as secondary outcomes.
Biomechanical data will be collected to study gait patterns. To ensure the accuracy of the biomechanical data, the investigators may gather additional data on the participant's gait patterns using a ten-camera motion analysis system (VICON) that is equipped with force plates (AMTI). To track participant movement, reflective markers will be attached using bio-adhesive tape to the participant's lower limbs and trunk based on anatomical landmarks (for example: second metatarsal head, center of calcaneus, lateral malleolus, lateral shank, distal lateral epicondyles, lateral thigh, anterior superior iliac spine, and the sacrum). Reflective markers may also be placed on the prosthesis to track its movement. The VICON system includes standard video cameras to record the session. The investigators will ask study participants permission to video record the gait trials and use the material for scientific presentations.
Electromyographic (EMG) data may be collected to study the characteristics of lower extremity muscle activation patterns during gait. The investigators will follow the Surface Electromyography for the Non-Invasive Assessment of Muscles (SENIAM) guidelines to place electrodes on several lower extremity muscles. Those may include the following: gastrocnemius, tibialis anterior, peroneal longus, rectus femoris, vastus lateralis, biceps femoris, or gluteus maximus. EMG electrodes will be attached using bio-adhesive double-sided tape and secured with Coban (self-adherent wrap) if needed. Portable ultrasonography may be used to localize muscles for proper electrode placement at this time. To ensure proper contact, the skin will be prepped for the electrodes; the area will be cleaned with alcohol swabs and shaved if necessary. Data from the electrodes will be gathered simultaneously with an acquisition system synchronized with the motion analysis system.
In the event that the surface EMG (sEMG) is not sufficiently robust to carry out the trials, the investigators will move to needle-based electrodes. If it is determined that needle-based electrodes are to be used to collect EMG data on the residual limb of a given participant, the amputee participant will meet with a clinician on the protocol with significant experience working with placement of electrodes in residual limb musculature. Since the musculature on the residual limb will be different for each participant, the participants will be instructed to make test contractions (e.g. ankle dorsiflexion or plantarflexion) to assist in localizing muscle sites. Sterile fine-wire electrodes will then be placed by the clinician on the protocol in each of the muscles of interest. The needles for electrode placement are 27-gauge needles. These needles are used acutely in the clinical space to insert the fine-wire electrodes into the muscles. The needles are then removed, leaving behind the fine-wire electrode. The fine-wire electrode is extremely fine, with a diameter of .051 mm. Because electrode placement is minimally invasive, this will occur at the gait lab.
Each participant will be asked to complete gross motor task assessing static and dynamic balance in their shoes and with the prosthetic device they typically wear for community ambulation. The participant will be asked to do this several times until 5-10 trials with good foot contacts onto the force plates are collected for each side (leg) of the body. There will be regular rest breaks during testing. At the end of the session, a trained study investigator will perform a brief visual check of the areas where the surface electrodes were in contact with the skin to assess these pressure areas. This will mark the end of the study procedures.
- Conditions
- Lower Extremity Amputation, Trans-Tibial Amputation, Traumatic Lower Extremity Amputation, Agonist-Antagonist Myoneural Interface
- Being tested
- Modified Amputation, Standard Amputation
- Keywords
- Amputation, Kinematics, Gait
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Modified AmputationProcedure or surgery
Modified amputation procedure
Standard AmputationProcedure or surgery
Standard amputation procedure
| Study group | Role | What they receive |
|---|---|---|
| Ewing Amputees | Amputees who have previously undergone Agonist-Antagonist Myoneural Interface construction at the trans-tibial level Receives: Procedure: Modified Amputation | |
| Standard Amputees | Amputees who have previously undergone trans-tibial level amputations without the construction of Agonist-Antagonist Myoneural Interfaces Receives: Procedure: Standard Amputation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Duration of co-contraction of the ankle dorsi/plantar-flexor muscles during gait
The percentage of the gait cycle during which both the Tibialis Anterior and the Gastrocnemius muscles are active is estimated for the residuum and the contralateral side.
Measured: Baseline
Symmetry of duration of co-contraction of the ankle dorsi/plantar-flexor muscles during gait
This is estimated by calculating the difference between the duration of co-contraction for the residuum and for the contralateral limb.
Measured: Baseline
Secondary outcomes (2)
Symmetry of ankle power generation
This is estimated by calculating the difference between the peak ankle power generation on the affected side (i.e., prosthesis side) and the contralateral limb.
Measured: Baseline
Symmetry of peak knee flexion during stance
This is estimated by calculating the difference between the peak knee flexion for the residuum and for the contralateral limb.
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Apr 2024
- Study start17 May 2022
- Primary completion1 Dec 2026 (estimated)
- Study completion1 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (7)Papers the sponsor has linked to this study.
- Other trials for Lower Extremity AmputationStudies of the same condition, open and under way.
- More trials run by Brigham and Women's HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Enrolment
- 32 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Brigham and Women's Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Matthew Carty, Brigham and Women's Hospital
- Investigators
- Matthew Carty, MD, Principal investigator, Brigham and Women's Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06371209
- Sponsor's protocol ID
- 2022P000619
- Status last verified
- Jul 2026
- First submitted
- 5 Dec 2023
- Last updated
- 9 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: No plan for individual participant data sharing
Publications
Srinivasan SS, Diaz M, Carty M, Herr HM. Towards functional restoration for persons with limb amputation: A dual-stage implementation of regenerative agonist-antagonist myoneural interfaces. Sci Rep. 2019 Feb 13;9(1):1981. doi: 10.1038/s41598-018-38096-z.
PubMed 30760764Clites TR, Carty MJ, Ullauri JB, Carney ME, Mooney LM, Duval JF, Srinivasan SS, Herr HM. Proprioception from a neurally controlled lower-extremity prosthesis. Sci Transl Med. 2018 May 30;10(443):eaap8373. doi: 10.1126/scitranslmed.aap8373.
PubMed 29848665Srinivasan SS, Carty MJ, Calvaresi PW, Clites TR, Maimon BE, Taylor CR, Zorzos AN, Herr H. On prosthetic control: A regenerative agonist-antagonist myoneural interface. Sci Robot. 2017 May 31;2(6):eaan2971. doi: 10.1126/scirobotics.aan2971.
PubMed 33157872Clites TR, Carty MJ, Srinivasan S, Zorzos AN, Herr HM. A murine model of a novel surgical architecture for proprioceptive muscle feedback and its potential application to control of advanced limb prostheses. J Neural Eng. 2017 Jun;14(3):036002. doi: 10.1088/1741-2552/aa614b. Epub 2017 Feb 17.
PubMed 28211795Clites TR, Herr HM, Srinivasan SS, Zorzos AN, Carty MJ. The Ewing Amputation: The First Human Implementation of the Agonist-Antagonist Myoneural Interface. Plast Reconstr Surg Glob Open. 2018 Nov 16;6(11):e1997. doi: 10.1097/GOX.0000000000001997. eCollection 2018 Nov.
PubMed 30881798Ziegler-Graham K, MacKenzie EJ, Ephraim PL, Travison TG, Brookmeyer R. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil. 2008 Mar;89(3):422-9. doi: 10.1016/j.apmr.2007.11.005.
PubMed 18295618Brown BJ, Iorio ML, Klement M, Conti Mica MR, El-Amraoui A, O'Halloran P, Attinger CE. Outcomes after 294 transtibial amputations with the posterior myocutaneous flap. Int J Low Extrem Wounds. 2014 Mar;13(1):33-40. doi: 10.1177/1534734614520706. Epub 2014 Feb 6.
PubMed 24510319
Study at a glance
From the registry record, last updated by the sponsor on 9 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Validating Normal Kinematic Motion in Residual Limb Musculature of Ewing Amputees
- ClinicalTrials.gov ID
- NCT06371209
- Acronym / sponsor ID
- 2022P000619
- Conditions
- Lower Extremity Amputation, Trans-Tibial Amputation, Traumatic Lower Extremity Amputation, Agonist-Antagonist Myoneural Interface
- Keywords
- Amputation, Kinematics, Gait
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 32 participants (estimated)
- Lead sponsor
- Brigham and Women's HospitalUniversity, hospital or other
- Study start
- 17 May 2022 (actual)
- Primary completion
- 1 Dec 2026 (estimated)
- Study completion
- 1 Dec 2026 (estimated)
- First posted
- 17 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The agonist-antagonist myoneural interface (AMI) construct, known as the Ewing amputation at the trans-tibial level, has been shown to create a bi-directional neural communication platform as a means of controlling and interpreting proprioceptive feedback from a prosthetic joint. In AMI constructs, agonist-antagonist muscles are mechanically coupled within the residual limb, and volitional contraction of an agonist passively stretches that muscle's antagonist. The natural neural responses from muscle spindles within both muscles are then interpreted by the central nervous system as sensations of joint position and speed, associated with movement of the prosthesis.
The aim of this research protocol is to evaluate the electromyographic and kinematic patterns of participants who have undergone unilateral lower extremity Ewing Amputation in order to determine how similar their residual limb data is when compared to their intact limb data. A secondary aim of this research may include comparison of the Ewing participant cohort's biomechanical patterns to a similar cohort of participants who have undergone standard amputation.
The investigators hypothesize that the affected limb of patients with the Ewing procedure will demonstrate a pattern of electromyographic activation of their AMI constructs and kinematic data that recapitulates the pattern seen in their intact limb. The investigators secondarily hypothesize that the kinematic assessment of Ewing Amputation patients will demonstrate patterns that are significantly more physiologic than those witnessed in similar assessments of standard amputees.
Detailed description
The specific aim of this research protocol is to evaluate the electromyographic and kinematic patterns of participants who have undergone unilateral lower extremity Ewing Amputation in order to determine how similar their residual limb data is when compared to their intact limb data. A secondary aim of this research may include comparison of the Ewing participant cohort's biomechanical patterns to a similar cohort of participants who have undergone standard amputation.
The investigators hypothesize that the affected limb of participants with the Ewing procedure will demonstrate a pattern of electromyographic activation of their AMI constructs and kinematic data that recapitulates the pattern seen in their intact limb. The investigators secondarily hypothesize that the kinematic assessment of Ewing Amputation participants will demonstrate patterns that are significantly more physiologic than those witnessed in similar assessments of standard amputees.
This will be a cross-sectional study with only one visit. A convenience sample of 16 participants who have previously undergone a lower extremity Ewing amputation will be recruited for the proposed study. Participants may subsequently be matched with up to 16 control participants who have previously undergone standard amputation procedures.
Participants will be assessed in a single session in the Motion Analysis Lab (MAL) at Spaulding Rehabilitation Hospital (SRH). Each visit will consist of the procedures described below and is expected to last about two and a half (2.5) hours.
The investigators will collect demographic data for each participant to help with the study population characterization. Such data will include questions about past medical and surgical history, height, weight, and prosthetic and functional history. In addition to self-reported data from the participant, the investigators may review the electronic medical record of any Mass General Brigham (MGB) participant in order to confirm demographic information.
Clinical tests may be conducted by the investigators to assess participant's lower extremities. Clinical tests may include functional examination of each participant's range of motion (ROM) and muscular strength for the lower extremities. Passive hip movements (flexion, abduction, adduction, internal and external rotation), knee flexion and extension, and ankle dorsiflexion and plantar flexion may be assessed with a goniometer if the joint is present for each limb.
Gait evaluations will be performed in the MAL during one session. Participants will be asked to change into shorts and a short-sleeved shirt (such articles of clothing can be provided by the lab if needed). Data will be gathered simultaneously with an electromyographic (EMG) system and a motion capture system. Both systems are part of SRH inventory and are routinely used in clinical care.
The spatio-temporal parameters, kinematic data and electromyographic data obtained from the Motion Capture System are the primary outcomes. As an exploratory analysis, the investigators will seek the possibility of assessing other items such as symmetry measurements and energy recovery as secondary outcomes.
Biomechanical data will be collected to study gait patterns. To ensure the accuracy of the biomechanical data, the investigators may gather additional data on the participant's gait patterns using a ten-camera motion analysis system (VICON) that is equipped with force plates (AMTI). To track participant movement, reflective markers will be attached using bio-adhesive tape to the participant's lower limbs and trunk based on anatomical landmarks (for example: second metatarsal head, center of calcaneus, lateral malleolus, lateral shank, distal lateral epicondyles, lateral thigh, anterior superior iliac spine, and the sacrum). Reflective markers may also be placed on the prosthesis to track its movement. The VICON system includes standard video cameras to record the session. The investigators will ask study participants permission to video record the gait trials and use the material for scientific presentations.
Electromyographic (EMG) data may be collected to study the characteristics of lower extremity muscle activation patterns during gait. The investigators will follow the Surface Electromyography for the Non-Invasive Assessment of Muscles (SENIAM) guidelines to place electrodes on several lower extremity muscles. Those may include the following: gastrocnemius, tibialis anterior, peroneal longus, rectus femoris, vastus lateralis, biceps femoris, or gluteus maximus. EMG electrodes will be attached using bio-adhesive double-sided tape and secured with Coban (self-adherent wrap) if needed. Portable ultrasonography may be used to localize muscles for proper electrode placement at this time. To ensure proper contact, the skin will be prepped for the electrodes; the area will be cleaned with alcohol swabs and shaved if necessary. Data from the electrodes will be gathered simultaneously with an acquisition system synchronized with the motion analysis system.
In the event that the surface EMG (sEMG) is not sufficiently robust to carry out the trials, the investigators will move to needle-based electrodes. If it is determined that needle-based electrodes are to be used to collect EMG data on the residual limb of a given participant, the amputee participant will meet with a clinician on the protocol with significant experience working with placement of electrodes in residual limb musculature. Since the musculature on the residual limb will be different for each participant, the participants will be instructed to make test contractions (e.g. ankle dorsiflexion or plantarflexion) to assist in localizing muscle sites. Sterile fine-wire electrodes will then be placed by the clinician on the protocol in each of the muscles of interest. The needles for electrode placement are 27-gauge needles. These needles are used acutely in the clinical space to insert the fine-wire electrodes into the muscles. The needles are then removed, leaving behind the fine-wire electrode. The fine-wire electrode is extremely fine, with a diameter of .051 mm. Because electrode placement is minimally invasive, this will occur at the gait lab.
Each participant will be asked to complete gross motor task assessing static and dynamic balance in their shoes and with the prosthetic device they typically wear for community ambulation. The participant will be asked to do this several times until 5-10 trials with good foot contacts onto the force plates are collected for each side (leg) of the body. There will be regular rest breaks during testing. At the end of the session, a trained study investigator will perform a brief visual check of the areas where the surface electrodes were in contact with the skin to assess these pressure areas. This will mark the end of the study procedures.
Study design
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Ewing Amputees | – | Procedure: Modified AmputationAmputees who have previously undergone Agonist-Antagonist Myoneural Interface construction at the trans-tibial level |
| Standard Amputees | – | Procedure: Standard AmputationAmputees who have previously undergone trans-tibial level amputations without the construction of Agonist-Antagonist Myoneural Interfaces |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Trans-tibial amputees local to or visiting the Massachusetts area
Key inclusion criteria (7 listed)
- Unilateral lower extremity amputees
- Greater than 12 months post-amputation procedure
- Possession and use of a working prosthesis as determined by subject's ability to wear it for 8 hours daily
- A stable, well-fitting socket as indicated by no prosthetic modifications within the prior 14 days and no plans to modify it within the following 30 days
- Follow-up visit with their prosthetist within the past 3 months
Key exclusion criteria (4 listed)
- Patients beyond the stated age restrictions will be excluded
- Patients who have any underlying neurologic, orthopedic, or cardiopulmonary impairment that affects their gait as assessed by the study clinician.
- Patients with any medical or functional limitations preventing them from ambulating safely and independently without an assistive device.
- Patients will be excluded who do not have a prosthesis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Modified AmputationModified amputation procedure | Procedure or surgery | Ewing Amputees |
| Standard AmputationStandard amputation procedure | Procedure or surgery | Standard Amputees |
Primary outcome
Duration of co-contraction of the ankle dorsi/plantar-flexor muscles during gait
Time frame: Baseline
The percentage of the gait cycle during which both the Tibialis Anterior and the Gastrocnemius muscles are active is estimated for the residuum and the contralateral side.
Symmetry of duration of co-contraction of the ankle dorsi/plantar-flexor muscles during gait
Time frame: Baseline
This is estimated by calculating the difference between the duration of co-contraction for the residuum and for the contralateral limb.
2 secondary outcomes
Symmetry of ankle power generation
Time frame: Baseline
Symmetry of peak knee flexion during stance
Time frame: Baseline
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jul 2026.
- Background: PubMed 30760764Srinivasan SS, Diaz M, Carty M, Herr HM. Towards functional restoration for persons with limb amputation: A dual-stage implementation of regenerative agonist-antagonist myoneural interfaces. Sci Rep. 2019 Feb 13;9(1):1981. doi: 10.1038/s41598-018-38096-z.
- Background: PubMed 29848665Clites TR, Carty MJ, Ullauri JB, Carney ME, Mooney LM, Duval JF, Srinivasan SS, Herr HM. Proprioception from a neurally controlled lower-extremity prosthesis. Sci Transl Med. 2018 May 30;10(443):eaap8373. doi: 10.1126/scitranslmed.aap8373.
- Background: PubMed 33157872Srinivasan SS, Carty MJ, Calvaresi PW, Clites TR, Maimon BE, Taylor CR, Zorzos AN, Herr H. On prosthetic control: A regenerative agonist-antagonist myoneural interface. Sci Robot. 2017 May 31;2(6):eaan2971. doi: 10.1126/scirobotics.aan2971.
- Background: PubMed 28211795Clites TR, Carty MJ, Srinivasan S, Zorzos AN, Herr HM. A murine model of a novel surgical architecture for proprioceptive muscle feedback and its potential application to control of advanced limb prostheses. J Neural Eng. 2017 Jun;14(3):036002. doi: 10.1088/1741-2552/aa614b. Epub 2017 Feb 17.
- Background: PubMed 30881798Clites TR, Herr HM, Srinivasan SS, Zorzos AN, Carty MJ. The Ewing Amputation: The First Human Implementation of the Agonist-Antagonist Myoneural Interface. Plast Reconstr Surg Glob Open. 2018 Nov 16;6(11):e1997. doi: 10.1097/GOX.0000000000001997. eCollection 2018 Nov.
- Background: PubMed 18295618Ziegler-Graham K, MacKenzie EJ, Ephraim PL, Travison TG, Brookmeyer R. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil. 2008 Mar;89(3):422-9. doi: 10.1016/j.apmr.2007.11.005.
- Background: PubMed 24510319Brown BJ, Iorio ML, Klement M, Conti Mica MR, El-Amraoui A, O'Halloran P, Attinger CE. Outcomes after 294 transtibial amputations with the posterior myocutaneous flap. Int J Low Extrem Wounds. 2014 Mar;13(1):33-40. doi: 10.1177/1534734614520706. Epub 2014 Feb 6.
- Individual participant dataSharing planned: No. No plan for individual participant data sharing
Related trials for Lower Extremity Amputation
RecruitingObservational study
Usability of the Smart Hallway System in Clinical Setting
Amputation, Gait Disorders, Neurologic
Not yet recruitingPhase 4
Role of Perineural Catheter in Pain Control and Opioid Consumption After Major Amputation of Lower Limb
Lower Limb Surgery, Pain
Recruiting
Bio Leg: Advancing Mobility (BAM)
Amputation of Lower Limb Above Knee, Amputee
Recruiting
Impact of Footwear on Gait in Unilateral Transtibial Amputees
Transtibial Amputation, Lower Limb Amputation
Recruiting
Prosthetic Socket Fit Testing System
Amputation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Matthew Carty, MD principal investigator
Brigham and Women's Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Lower Extremity Amputation and Trans-Tibial Amputation, run by Brigham and Women's Hospital at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 9 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Duration of co-contraction of the ankle dorsi/plantar-flexor muscles during gait (time frame: Baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06371209, which also lists 7 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2026.